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Introduction {#sec1}
============

Naive B cells express a B cell receptor (BCR) composed of the nonsignaling membrane immunoglobulins (Ig) IgM and IgD, which recognize extracellular antigen, and the associated signaling transmembrane components Ig-α and Ig-β, containing immunoreceptor tyrosine-based activation motifs (ITAMs) ([@bib39; @bib49]). Cognate antigen recognition by the BCR initiates rapid phosphorylation of the ITAMs, which form a signaling platform for the tyrosine kinases Lyn and Syk. Subsequently both kinases recruit and phosphorylate several adaptor proteins and the co-receptor CD19. CD19 further recruits other molecules such as the Vav adaptor protein, Bruton's tyrosine kinase (Btk), the PI3 kinase (PI3K) subunit p85α and Lyn itself via its cytosolic domain thus lowering the threshold of B cell activation ([@bib8]). In addition, CD19 plays a prominent role in PI3K pathway activation after BCR ligation ([@bib34]).

To initiate the signaling cascade, early antigen recognition requires alteration of the actin cytoskeleton, enabling the spreading and contraction of B cells across the surface of antigen-presenting cells ([@bib17]). Antigen-induced BCR signaling leads to an early rapid wave of actin depolymerization that is dependent on the amount of BCR cross-linking ([@bib22]). This radical reorganization of the actin cytoskeleton removes barriers to BCR diffusion and modifies BCR dynamics at the cell surface. In addition, TLR signaling has been shown to influence actin organization, thereby increasing BCR mobility and facilitating BCR signaling ([@bib18]). Furthermore, changes in actin organization alone increases BCR diffusion and triggers signaling similar to BCR crosslinking ([@bib47]). This ligand-independent signal not only requires increased BCR diffusion but also an immobilized co-receptor CD19, held in place by its association with the tetraspanin molecule CD81 ([@bib30]). In this context, we believe CD19 provides a mechanism for signal amplification via the PI3K pathway; however, the molecular linkage between CD19, the PI3K pathway, and the actin cytoskeleton is incompletely defined.

The PI3K pathway is one of the main signaling pathways regulating B cell homeostasis, survival, differentiation, and class-switch recombination. In addition to the BCR, several other receptors have been shown to activate the PI3K pathway in B cells, including chemokine and cytokine receptors, Toll-like receptors and receptors of the tumor necrosis factor (TNF) family, namely BAFFR and CD40 ([@bib3; @bib35]). Recently, it has been suggested that CD19 also mediates PI3K signaling in response to BAFFR or CD40 stimulation ([@bib23; @bib24]) and raises the question of a general involvement of CD19 in PI3K activation in B cells.

WIP, the Wiskott-Aldrich syndrome protein (WASP) interacting protein, which is encoded by the *Wipf1* gene, plays a key regulatory role in remodeling of the actin cytoskeleton. WIP binding to WASP, a central activator of the Arp2/3 complex, protects it from degradation and regulates its cellular distribution ([@bib19]). WIP promotes actin polymerization independently of WASP by binding and stabilizing actin filaments ([@bib28; @bib36]). Furthermore, WIP associates with the adaptor molecules Nck and Grb2, thus potentially linking the actin network to signaling cascades ([@bib1; @bib5; @bib15; @bib31]).

In humans, mutations in the WIP binding site of WASP ([@bib44]) or in WIP itself ([@bib26]) results in the development of the immunodeficiency Wiskott-Aldrich syndrome (WAS). WAS is an X-linked disorder associated with eczema, increased susceptibility to infections and heightened risk of autoimmune disorders ([@bib46]). Mice deficient in WIP display severe lymphopenia, increased spleen size but reduced numbers of B cells, lack of marginal zone B cells and a severe T cell dysfunction thus mimicking WAS ([@bib12]). WIP-deficient B cells exhibit defects in their actin network and increased proliferation in response to BCR stimulation in vitro ([@bib2]); however, the role of WIP in B cell activation remains to be studied.

Here, we have shown that WIP deficiency in B cells resulted in defects in homing, chemotaxis, survival, and differentiation, ultimately leading to a reduction in germinal centers and antibody production in response to infection or immunization. These defects were the result of an impaired CD19 activation and PI3K signaling in WIP-deficient B cells after triggering a variety of receptors, namely BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR4. Addressing the underlying mechanism, we found a distorted actin cytoskeleton and CD81-tetraspanin network in WIP-deficient B cells, which resulted in altered cell surface mobility of CD19. On the basis of these findings, it appears that WIP, by controlling actin-dependent receptor dynamics, influences CD19 in its function as a general hub for PI3K signaling.

Results {#sec2}
=======

B Cell-Specific WIP Deficiency Impairs Mouse Immune Responses to Viral Infection or Immunization {#sec2.1}
------------------------------------------------------------------------------------------------

To establish whether the absence of WIP exclusively in B cells has any effect in altering humoral immune responses, we generated mixed bone marrow (BM) chimeras by adoptively transferring a mix of WIP-deficient BM (from now on *Wipf1*^*−/−*^ cells referring to its standard gene symbol) and BM from mice that lack B cells (JHT mice) into lethally irradiated JHT recipients. In this setting, all newly generated B cells will be *Wipf1*^*−/−*^ in an environment containing mainly WT cells.

*Wipf1*^*−/−*^ and wild-type (WT) chimeric mice were challenged with a low dose (1 × 10^4^ PFU) of Vaccinia virus intra footpad. Eight days later, using flow cytometry, the generation of germinal center (GC) B cells was measured as a percentage of GL7^+^CD95^+^ of B220^+^ B cells. We observed a robust formation of GC B cells in the draining lymph node of WT chimeras, with 16% of B cells staining positive for GC markers. This percentage was significantly diminished to 9% when B cells were deficient in WIP ([Figure 1](#fig1){ref-type="fig"}A). We also observed a marked diminution in the percentage of T follicular helper cells (CD4^+^CXCR5^+^PD1^+^) from 13% to 7% in *Wipf1*^*−/−*^ chimeras ([Figure 1](#fig1){ref-type="fig"}A), suggesting a defective interaction between *Wipf1*^*−/−*^ B cells and T cells.

Similar to our observations after Vaccinia virus infection, B cell responses were severely impaired when *Wipf1*^*−/−*^ chimeric mice were challenged with the T cell-dependent antigen NP-KLH. Here, the GC B cell population was reduced from 14.1% to 4.1% in *Wipf1*^*−/−*^ chimeras ([Figure 1](#fig1){ref-type="fig"}B). Furthermore, using confocal microscopy, we detected smaller Bcl-6^+^ GC in frozen sections of spleens from immunized *Wipf1*^*−/−*^ chimeras, with substantially reduced numbers of *Wipf1*^*−/−*^ GC cells compared to WT GC cells (an average of 22 *Wipf1*^*−/−*^ cells compared to an average of 970 WT cells) ([Figure 1](#fig1){ref-type="fig"}C). Quantifying NP-specific antibody titers in the serum, we found that *Wipf1*^*−/−*^ chimeras had about one-fifth of the NP-specific IgM antibody concentration compared to WT chimeras. Notably, the production of NP-specific IgG antibody titers was severely delayed and reduced with IgG1 and IgG3 antibodies titers being diminished by at least one-fourth in *Wipf1*^*−/−*^ chimeric mice ([Figure 1](#fig1){ref-type="fig"}D). The substantial reduction in the percentage of GC B cells and the differences in antibody production were unlikely to be due to a reduction of the percentage of circulating B cells in *Wipf1*^*−/−*^ chimeras to about half that of the WT chimeras ([Figures S1](#mmc1){ref-type="supplementary-material"}A and S1B), but mainly indicate an intrinsic differentiation defect in the absence of WIP. Furthermore, we observed a similarly impaired GC B cell response of *Wipf1*^*−/−*^ cells when we challenged chimeras reconstituted with a mixture of 50% CD45.2 *Wipf1*^*−/−*^ BM and 50% CD45.1 WT BM with NP-KLH in alum ([Figure S1](#mmc1){ref-type="supplementary-material"}C).

Collectively, these in vivo experiments suggest that B cell-specific WIP deficiency renders mice unable to respond effectively to viral infection or immunization.

*Wipf1*^−/−^ B Cells Show Impaired Homing and Migration {#sec2.2}
-------------------------------------------------------

During analysis of the mixed chimeras, we found the expected ratio of approx. 50:50 (50% CD45.1^+^ WT cells versus 50% CD45.2^+^ *Wipf1*^*−/−*^ cells) in the B cell compartment of the BM and the blood ([Figures 2](#fig2){ref-type="fig"}A and 2B). However, we observed a ratio of approx. 70:30 of CD45.1^+^ WT B cells versus CD45.2^+^ *Wipf1*^*−/−*^ B cells in the spleen and lymph node ([Figure 2](#fig2){ref-type="fig"}B). A similar difference in the percentages of cells homing to spleen and lymph nodes was observed when fluorescently labeled CD45.1^+^ WT and CD45.2^+^ *Wipf1*^*−/−*^ B cells were adoptively transferred into WT recipients ([Figure S2](#mmc1){ref-type="supplementary-material"}A). Together, these results indicate that *Wipf1*^*−/−*^ B cells might be deficient in their capacity to migrate and/or to sense chemokines.

We next investigated the steady-state migration of naive B cells in vivo. For this, fluorescently labeled WT and *Wipf1*^*−/−*^ B cells were adoptively transferred into WT recipients. After 24 hr, both cell types were found in similar regions of explanted popliteal and inguinal lymph nodes using two-photon microscopy, indicating that both cell types are able to localize to B cell follicles ([Figure 2](#fig2){ref-type="fig"}C). While WT B cells moved with an average speed of 6.2 ± 0.07 μm/min, *Wipf1*^*−/−*^ B cells were significantly slower with an average speed of 5.1 ± 0.1 μm/min ([Figure 2](#fig2){ref-type="fig"}C; [Movie S1](#mmc2){ref-type="supplementary-material"}). In addition, *Wipf1*^*−/−*^ B cells showed 30% less displacement during the acquisition period compared to WT B cells. These results support our hypothesis that WIP might regulate cell migration in vivo.

Homing of B cells to follicles in secondary lymphoid organs involves migration mediated by the chemokines CXCL12 and CXCL13 ([@bib33]). We found WIP to be slightly phosphorylated after stimulating naive B cells with CXCL12 as measured by flow cytometry ([Figure S2](#mmc1){ref-type="supplementary-material"}B), likely indicating an involvement of WIP in chemokine signaling. We next evaluated the B cell chemotactic response to a gradient of these chemokines in vitro using transwell plates. Here, *Wipf1*^*−/−*^ B cells displayed a significant reduction in the percentage of migratory B cells to both, CXCL12 and CXCL13 compared to WT cells ([Figure 2](#fig2){ref-type="fig"}D). This reduction was not due to altered expression of CXCR4 (the receptor binding CXCL12) and CXCR5 (the receptor binding CXCL13) on the B cell surface ([Figure S2](#mmc1){ref-type="supplementary-material"}C). Examining signaling after CXCR4 stimulation, *Wipf1*^*−/−*^ B cells displayed a severely diminished phosphorylation of Akt kinase, used as an indicator for PI3K signaling, when compared to WT B cells ([Figures 2](#fig2){ref-type="fig"}E and 2F). A similar reduced phosphorylation of Akt was observed in *Wipf1*^*−/−*^ WEHI-231 B cells. Re-expression of WIP in *Wipf1*^*−/−*^ WEHI B cells restored Akt phosphorylation to amounts similar to those in WT WEHI cells ([Figure S2](#mmc1){ref-type="supplementary-material"}E). Furthermore, splenic *Wipf1*^*−/−*^ B cells showed a 50% reduction in phosphorylation of the transcription factor Foxo and a 80% reduction in phosphorylation of p70S6K compared to the phosphorylation in WT cells, both downstream targets of the PI3K signaling pathway ([Figures 2](#fig2){ref-type="fig"}E and 2F; [Figure S2](#mmc1){ref-type="supplementary-material"}D). *Wipf1*^*−/−*^ B cells stimulated with CXCL13 similarly displayed severely diminished activation of the PI3K/Akt signaling pathway when compared to WT cells ([Figures 2](#fig2){ref-type="fig"}E and 2F; [Figure S2](#mmc1){ref-type="supplementary-material"}D).

Together, these results demonstrate an impaired chemokine receptor-induced PI3K signaling in *Wipf1*^*−/−*^ B cells. In line with this, we also found reduced chemokine-sensing and migration of these cells in vitro and in vivo, which likely contributes to a decreased humoral immune response in *Wipf1*^*−/−*^ mice.

BCR Signaling Requires WIP for PI3K Pathway Activation {#sec2.3}
------------------------------------------------------

To address whether WIP was recruited to active sites of BCR signaling, we expressed human GFP-WIP in WEHI-231 B cells. These cells were settled on planar lipid bilayers containing Alexa Fluor 633-labeled antibody against the BCR (anti-BCR) to mimic the interaction of B cells with antigen-presenting cells ([@bib17]). Immediately after B cells contacted the membrane, GFP-WIP was recruited to sites of antigen aggregation ([Figure 3](#fig3){ref-type="fig"}A and [Movie S2](#mmc3){ref-type="supplementary-material"}). In parallel, we found strong phosphorylation of WIP at residue S488 already 3 min after BCR cross-linking of naive WT B cells, as detected by flow cytometry ([Figure 3](#fig3){ref-type="fig"}B) or immunoblot ([Figure S3](#mmc1){ref-type="supplementary-material"}A). These findings demonstrate that during early events of BCR signaling, WIP is recruited to signalosomes. This recruitment is concomitant with an increase in phosphorylation of the protein.

We next investigated whether ablation of WIP influences the quantity of filamentous actin (F-actin) in activated B cells. We found that *Wipf1*^*−/−*^ B cells exhibited a lower amount of F-actin when B cells were allowed to spread on coverslips coated with immobilized antigen. Such difference was mainly manifested by the absence of visible F-actin foci measured by total internal reflection microscopy (TIRFM) (with an average of 6.8 F-actin foci per WT cell compared to an average of 0.8 F-actin foci in *Wipf1*^*−/−*^ cells), but resulted neither in the incapacity to spread nor in a defect of F-actin polymerization at the leading edge ([Figure 3](#fig3){ref-type="fig"}C).

We next tested the capacity of *Wipf1*^*−/−*^ cells to internalize antigen. B cells were loaded with fluorescent microspheres containing anti-κ-chain antibody on ice, washed to remove unbound microspheres, and then incubated at 37°C to allow BCR internalization. *Wipf1*^*−/−*^ B cells internalized less particulate antigen compared to WT B cells at all time-points analyzed ([Figure S3](#mmc1){ref-type="supplementary-material"}B), indicating that WIP-mediated reorganization of the actin cytoskeleton might be necessary for BCR-mediated antigen internalization.

We went on to measure BCR-induced Ca^2+^ mobilization in naive splenic B cells by flow cytometry and found it to be increased in *Wipf1*^*−/−*^ B cells relative to that of WT B cells ([Figure S3](#mmc1){ref-type="supplementary-material"}D). This was not due to increased BCR expression on the surface of *Wipf1*^*−/−*^ B cells ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Next, we stimulated both cell types with a soluble anti-κ-chain antibody and measured the BCR-induced phosphorylation of Syk and Erk kinases, as well as the PI3K subunit p85, Akt and Foxo. Both WT and *Wipf1*^*−/−*^ B cells displayed robust phosphorylation of Syk and Erk after BCR cross-linking. Of note, naive *Wipf1*^*−/−*^ B cells expressed higher basal phosphorylation of Syk and Erk ([Figures 3](#fig3){ref-type="fig"}D and 3E). However, *Wipf1*^*−/−*^ B cells showed an at least 50% reduction of phosphorylation of p85, Akt and Foxo compared to WT cells ([Figures 3](#fig3){ref-type="fig"}D and 3E). Similar results for Erk and Akt phosphorylation after stimulation were obtained using flow cytometry ([Figure S3](#mmc1){ref-type="supplementary-material"}E).

We next investigated whether WIP deficiency influences B cell survival. In addition to BCR signaling, the BAFFR pathway is critical for survival of B cells. We detected slightly lower expression of BAFFR on the surface of *Wipf1*^*−/−*^ B cells compared to WT cells by flow cytometry ([Figure S3](#mmc1){ref-type="supplementary-material"}F). Cultivating purified splenic B cells from *Wipf1*^*−/−*^ or WT mice in either unconditioned medium or in the presence of BAFF, we found reduced survival in the absence of WIP. In cultures with BAFF, only 40% of *Wipf1*^*−/−*^ B cells were alive at day 3 compared to 60% of WT B cells ([Figure 3](#fig3){ref-type="fig"}F). In line with the impaired survival, phosphorylation of Akt was impaired in *Wipf1*^*−/−*^ B cells after short-term stimulation with BAFF ([Figure 3](#fig3){ref-type="fig"}G). These results suggest a role of WIP in BAFFR-induced PI3K activation and survival.

Collectively, these results demonstrate that, in the absence of WIP, the actin cytoskeleton after BCR stimulation is altered. Furthermore, WIP deficiency led to impaired PI3K signaling after BCR cross-linking, which eventually results in a reduced BAFFR-triggered survival.

Formation of Plasma Cells In Vitro Depends on WIP Mediated PI3K Signaling {#sec2.4}
-------------------------------------------------------------------------

We went on to measure phosphorylation of WIP in response to CD40 and Toll-like receptor-4 (TLR4) stimulation by flow cytometry and immunoblot, respectively, and found WIP to be phosphorylated, again indicating a direct contribution of WIP in response to those stimuli ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). We next analyzed the activation status of Akt and Foxo after triggering CD40 and TLR4 in WT and *Wipf1*^*−/−*^ B cells by immunoblot. We observed robust phosphorylation of Akt and Foxo in WT B cells, but phosphorylation of both was strongly reduced in *Wipf1*^*−/−*^ B cells ([Figures 4](#fig4){ref-type="fig"}A and 4B), similar to our results after BCR and chemokine receptor stimulation. Furthermore, we measured reduced phosphorylation of Akt after CD40 stimulation of *Wipf1*^*−/−*^ WEHI-231 B cells by flow cytometry, which was restored to the amount of phosphorylation in WT cells after re-expression of WIP ([Figure S4](#mmc1){ref-type="supplementary-material"}F). Thus, WIP deficiency might indeed lead to a general impaired PI3K and Akt activation.

We next analyzed whether the defect in PI3K/Akt signaling was reflected in the capability of *Wipf1*^*−/−*^ B cells to class-switch and differentiate into plasma cells (PCs). Splenic WT and *Wipf1*^*−/−*^ B cells were cultivated with either CD40L or LPS in the presence or absence of interleukin-4 (IL-4) and IL-5 in vitro. After four days of culture, both, *Wipf1*^*−/−*^ and WT B cells proliferated extensively to CD40L stimulation as indicated by the dilution of CTV ([Figure 4](#fig4){ref-type="fig"}C). However, in response to LPS or LPS in the presence of IL-4 and IL-5, *Wipf1*^*−/−*^ B cells showed a marked increase in the percentage of proliferating cells of 80% versus 50% when compared to WT B cells ([Figure 4](#fig4){ref-type="fig"}D). This correlated with an increase in Erk phosphorylation as detected by immunoblot ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E). Furthermore, *Wipf1*^*−/−*^ B cells showed a 2--3 times higher percentage of class-switched cells compared to WT cells in both stimulatory conditions ([Figures 4](#fig4){ref-type="fig"}C and 4D). The proportion of *Wipf1*^*−/−*^ PCs (evaluated by CD138 expression) was substantially diminished to less than half ([Figures 4](#fig4){ref-type="fig"}C and 4D). Taken together, these results indicate that WIP is required for PI3K pathway activation and thus regulates class-switch recombination and plasma cell formation.

WIP Regulates PI3K Activation via Phosphorylation of CD19 {#sec2.5}
---------------------------------------------------------

Having identified an essential function for WIP in regulating PI3K/Akt signaling in response to stimulation of chemokine receptors, BAFFR, cross-linking of the BCR or the co-receptor CD40 or TLR4, we wondered whether the co-receptor CD19 itself might be involved in all the signaling pathways we analyzed. As expected, triggering of the BCR, BAFFR, and CD40 induced robust phosphorylation of CD19 ([Figures 5](#fig5){ref-type="fig"}A and 5B). Triggering of TLR4, CXCR4, and CXCR5 also induced low but consistent phosphorylation of CD19 ([Figures 5](#fig5){ref-type="fig"}A and 5B). Furthermore, we noted that, in B cells lacking WIP, basal CD19 phosphorylation was reduced, likely contributing to overall reduced CD19 phosphorylation after stimulation. We found that triggering CD40, TLR4, and CXCR4 induced phosphorylation of Src family kinases and that this phosphorylation was again reduced in the absence of WIP ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Together, these results indicate that CD19 is not only a critical component of the BCR, BAFFR, and CD40 pathway but might also be relevant for PI3K signaling after TLR4, CXCR4, and CXCR5 stimulation. In addition, WIP is involved in these signaling pathways possibly influencing the phosphorylation of CD19.

*Cd19*^*−/−*^ mice have been repeatedly used to study the role of the PI3K/Akt pathway in B cell function ([@bib14; @bib16; @bib20; @bib40]). We used B cells from *Cd19*^*−/−*^ mice to compare results of experiments performed under similar conditions. Of note, BCR cross-linking of *Cd19*^*−/−*^ B cells induced a robust phosphorylation of WIP ([Figure S5](#mmc1){ref-type="supplementary-material"}E), suggesting that WIP activation might be independent of CD19 signaling. We went on to investigate the effect of CD19 deficiency on plasma cell formation in vitro. Splenic purified B cells from *Cd19*^*−/−*^ and WT mice were cultivated with either LPS or CD40L in the presence or absence of IL-4 and IL-5 as described before. After 4 days in culture, both, *Cd19*^*−/−*^ and WT B cells proliferated extensively ([Figure 5](#fig5){ref-type="fig"}C and [Figure S5](#mmc1){ref-type="supplementary-material"}C). In similarity to what has been observed in cultures of *Wipf1*^*−/−*^ B cells, the proportion of *Cd19*^*−/−*^ B cells that underwent class-switch recombination was about 2-fold higher compared to WT cells when stimulated with CD40L ([Figure 5](#fig5){ref-type="fig"}D). However, class-switch recombination of *Cd19*^*−/−*^ B cells in response to LPS was comparable to WT cells ([Figure S5](#mmc1){ref-type="supplementary-material"}B). Furthermore, *Cd19*^*−/−*^ B cells demonstrated a complete block in differentiation into CD138-positive PCs ([Figure 5](#fig5){ref-type="fig"}D). In line with these results, and similar to results obtained with *Wipf1*^*−/−*^ B cells, *Cd19*^*−/−*^ B cells showed reduced Akt and Foxo phosphorylation after CD40L or LPS stimulation ([Figures 5](#fig5){ref-type="fig"}E and 5F and [Figure S5](#mmc1){ref-type="supplementary-material"}D).

Again similar to results with *Wipf1*^*−/−*^ B cells, we found that the chemotaxis of *Cd19*^*−/−*^ B cells toward a gradient of CXCL13 using transwell plates was significantly reduced compared to WT B cells ([Figure 5](#fig5){ref-type="fig"}G). In addition, *Cd19*^*−/−*^ B cells displayed diminished phosphorylation of Akt and Foxo in response to CXCL13 stimulation compared to WT cells ([Figure 5](#fig5){ref-type="fig"}H). These experiments demonstrate that *Cd19*^*−/−*^ B cells recapitulate many of the phenotypes observed in *Wipf1*^*−/−*^ B cells, providing strong evidence that WIP is involved in regulating the PI3K pathway via CD19 activation.

WIP Regulates BCR and CD19 Diffusion on the B Cell Surface {#sec2.6}
----------------------------------------------------------

How could WIP affect CD19 activation? We noticed that while CD19 expression was similar on the surface of WT and *Wipf1*^*−/−*^ B cells, expression of the tetraspanin protein CD81 was reduced on *Wipf1*^*−/−*^ B cells ([Figure 6](#fig6){ref-type="fig"}A). No substantial alterations in the expression of other members of the tetraspanin family were detected in the absence of WIP (data not shown). A reduction in CD81 was also observed in two independent *Wipf1*^*−/−*^ cell lines generated by employing the CRISPR/Cas9 deletion system. Transient re-expression of WIP in *Wipf1*^*−/−*^ A20 cells increased CD81 expression ([Figures S6](#mmc1){ref-type="supplementary-material"}A--S6D) further supporting the notion that WIP is required to maintain CD81 expression.

In resting B cells, CD81 stabilizes and immobilizes CD19 on the cell surface ([@bib30]). To investigate whether WIP deficiency alters CD19 dynamics, we performed single-particle tracking of CD19 by incubating primary B cells with limited amounts of fluorescently labeled anti-CD19 Fab fragments followed by analysis with TIRFM. While CD19 was relatively immobile on the surface of resting WT cells, CD19 particles on the surface of *Wipf1*^*−/−*^ B cells showed an accelerated diffusion, with the median diffusion coefficient increasing from 0.008 μm^2^/s on WT B cells to 0.03 μm^2^/s on *Wipf1*^*−/−*^ B cells ([Figures 6](#fig6){ref-type="fig"}B and 6C and [Movie S3](#mmc4){ref-type="supplementary-material"}). A more detailed analysis revealed two different populations of CD19 in WT cells, with a slower diffusion population centered around D = 0.003 μm^2^/s and a population retaining higher mobility (centered around D = 0.032 μm^2^/s). CD19 diffusion of both, the slower and higher populations accelerated on *Wipf1*^*−/−*^ B cells with the slower diffusion population centered around D = 0.010 μm^2^/s and the higher diffusion population centered around D = 0.060 μm^2^/s) ([Figure 6](#fig6){ref-type="fig"}D). These results indicate that the reduced CD81 amount indeed correlate with an increase in CD19 dynamics, likely leading to a misplacement of the co-receptor.

We went on to analyze the impact of WIP deficiency on BCR dynamics on resting B cells. While CD19 is immobilized by the tetraspanin network, BCR mobility is regulated by the cortical actin cytoskeleton. Measuring phalloidin staining by flow cytometry, we observed a reduced amount of F-actin in naive *Wipf1*^*−/−*^ B cells when compared to WT B cells ([Figure 6](#fig6){ref-type="fig"}E). Given this reduction in F-actin in steady state and the impaired actin polymerization after BCR stimulation, we wondered whether the diffusion of the BCR was altered in the absence of WIP. As previously shown ([@bib30]), we observed a very low mobility of a large proportion of IgD particles in resting WT B cells, with a median diffusion coefficient of 0.008 μm^2^/s. Notably, on *Wipf1*^*−/−*^ B cells, we detected a 2-times accelerated diffusion of IgD particles, with a median diffusion coefficient of 0.015 μm^2^/s ([Figure 6](#fig6){ref-type="fig"}F, right graph). Although IgM is already quite mobile on resting WT B cells, we detected a slight but consistent increase also in IgM diffusion on *Wipf1*^*−/−*^ B cells ([Figure 6](#fig6){ref-type="fig"}F, left graph). The diffusion of CD40 was also accelerated on *Wipf1*^*−/−*^ B cells ([Figure S6](#mmc1){ref-type="supplementary-material"}F). From these results, we conclude that the diminished amount of F-actin in *Wipf1*^*−/−*^ B cells is reflected in higher mobility of B cell receptors.

In view of the impaired CD19 phosphorylation and the altered dynamics of CD19, we next analyzed whether *Wipf1*^*−/−*^ B cells were able to react to the disruption of the actin cytoskeleton through the actin monomer-sequestering agent Latrunculin A (LatA). Compared to WT cells, *Wipf1*^*−/−*^ B cells displayed a markedly delayed calcium response to LatA treatment together with a severely impaired capability to phosphorylate the co-receptor CD19 and the signaling molecules Akt, Syk, and Erk ([Figures 6](#fig6){ref-type="fig"}G and 6H). These results show that in the absence of WIP, ligand-independent signaling via CD19 triggered by actin cytoskeleton disruption is distorted, again hinting at the regulatory effect of WIP in mediating CD19 activation. We thus suggest that in the absence of WIP, the actin cytoskeleton but also the CD81 tetraspanin network is disturbed, leading to an increased diffusion of both, the BCR and CD19 on resting cells. This possibly causes an altered organization of B cell surface receptors, leading to a misplacement of the receptors and impaired signaling.

Discussion {#sec3}
==========

Here, we have shown that WIP functions as a regulator of CD19 activation and PI3K/Akt signaling in B cells. WIP deficiency resulted in defects in homing, chemotaxis, survival and differentiation, highlighting an essential role for WIP in B cell function. Furthermore, in the absence of WIP, B cells displayed distortions in the actin cytoskeleton and the CD81-tetraspanin network, which resulted in altered cell surface mobility of the BCR and CD19. These changes in surface receptor dynamics resulted in reduced phosphorylation of CD19 after triggering a variety of receptors and thus place CD19 at the heart of PI3K signaling in B cells.

Challenging mixed BM chimeras with either Vaccinia virus or NP-KLH revealed that WIP deficiency compromised GC formation and antibody production, thereby hampering humoral immune responses. Similarly, the small Rho GTPase Cdc42, a known regulator of actin remodeling and interaction partner of WASP and N-WASP, controls GC formation and antibody production in B cells ([@bib7]). In contrast, B cells deficient for WASP mount a normal antibody response to T-dependent immunization ([@bib38; @bib43]). This can be partly explained by compensatory effects of the ubiquitously expressed protein N-WASP ([@bib50]). We therefore suggest that the impaired capability of our mixed BM chimeras to mount a humoral immune response is due to the absence of WIP in B cells.

We have further shown that WIP regulated chemotaxis of B cells toward the chemokines CXCL12 and CXCL13, mediating B cell homing to lymph nodes and spleen. In support of our findings, WIP functions in F-actin-rich lamellopodium formation and amoeboid motility in response to CXCL13 in vitro ([@bib4]). T cells lacking the actin-binding domain of WIP displayed decreased cellular F-actin content, impaired chemotaxis and defective homing to lymph nodes although having normal WASP expression ([@bib21; @bib29]). These findings strongly argue for a crucial role for WIP in regulating actin-cytoskeleton-mediated migration.

Early signaling events following BCR stimulation by membrane-bound antigen trigger the formation of antigen microclusters ([@bib17]). We found here that WIP was recruited to microclusters and phosphorylated at the serine residue S488 immediately after BCR engagement, suggesting that WIP participates in the early events after antigen recognition. How phosphorylation regulates WIP function in B cells is unclear to date. In T cells, S488 of WIP is phosphorylated in a PKCΘ-dependent manner in response to T cell receptor (TCR) activation, mediating the recruitment of WASP to the immunological synapse ([@bib19; @bib41]). In contrast, tyrosine phosphorylation of WIP by Btk triggers the release of WASP from the WIP--WASP complex, resulting in WASP degradation and termination of actin filament generation ([@bib48]). Phosphorylation and activation of WIP in B cells might thus regulate actin dynamics. Indeed, in the absence of WIP, we found lower amounts of F-actin in resting B cells and less F-actin foci when B cells spread on antigen-coated coverslips. Similar F-actin foci were recently described as being a WASP-generated fraction of the total synaptic F-actin in T cells ([@bib25]). We suggest that, in B cells, WIP plays a central role in cytoskeletal actin dynamics that is triggered by the engagement of a variety of receptors, having shown that BCR crosslinking, CXCL12, CD40, and TLR4 signaling all induce the phosphorylation of WIP.

A high percentage of WAS patients develop autoimmune diseases. Similarly, B cell-intrinsic deletion of WASP is sufficient to induce autoantibody production and antibody deposition in the kidneys of mice ([@bib6; @bib38]). In the absence of the WASP homolog N-WASP, B cells show delayed BCR internalization, enhanced tyrosine phosphorylation and higher Ca^2+^ flux ([@bib27]). WIP interacts with N-WASP but is not required for its stability ([@bib13]). In *Wipf1*^*−/−*^ B cells, N-WASP activation upon BCR stimulation was only mildly impaired (data not shown), suggesting that the negative regulatory role of WIP is probably independent of N-WASP function. We found that *Wipf1*^*−/−*^ B cells displayed an increased Ca^2+^ flux after BCR crosslinking, enhanced proliferation, a delayed and reduced BCR internalization, and increased basal phosphorylation of Syk and Erk. These findings are in line with a previous report suggesting that blocking of BCR endocytosis leads to hyperphosphorylation of Syk and Erk and lower phosphorylation of the PI3K pathway ([@bib9]). We suggest that the higher basal Syk activation in *Wipf1*^*−/−*^ B cells might explain the partially hyperreactive phenotype, because Syk is both essential to and sufficient for antigen-induced Ca^2+^ flux after BCR clustering by multimeric ligands ([@bib32; @bib45]).

In B cells, CD19 contributes to BAFF- and CD40-mediated survival, consistent with CD19 phosphorylation and Akt activation ([@bib23; @bib24]). Here, we extend this model by showing that triggering a variety of receptors, namely the BCR, BAFFR, CXCR4, CXCR5, CD40, and TLR, led to the phosphorylation of CD19. We thus suggest a critical role for CD19 as a general "hub" of PI3K signaling. The precise molecular mechanism by which CD19 is phosphorylated remains unclear. Recent data demonstrated that BAFFR stimulation triggers the phosphorylation of the Igα chain and Syk, potentially leading to CD19 activation ([@bib42]). Furthermore, in a model of CD40 overexpression, CD19 phosphorylation is likely mediated by the Src family kinase Lyn ([@bib23]). We indeed detected Lyn phosphorylation after triggering of most of the receptors studied. We moreover have demonstrated here that CD19 phosphorylation is dependent on WIP. *Wipf1*^*−/−*^ B cells were unable to efficiently phosphorylate CD19. Concomitantly, activation of the PI3K/Akt pathway was impaired, leading to multiple defects in homing, survival, class-switching, and antibody production. Supporting our hypothesis, many of the defects seen in *Wipf1*^*−/−*^ B cells were recapitulated in B cells lacking CD19.

Dissecting the molecular mechanism of how WIP might mediate the function of CD19, we found that in the absence of WIP, BCR and CD19 diffusion is enhanced. We recently showed that in the plasma membrane of resting B cells, the BCR is immobilized by the actin cytoskeleton ([@bib47]) and CD19 is kept relatively immobile by the CD81-tetraspanin network ([@bib30]). Actin cytoskeleton disruption increases BCR diffusion, leading to signal induction. This ligand-independent signal not only requires an increased BCR diffusion but also an immobilized co-receptor CD19. In the absence of CD81, CD19 mobility on the B cell surface increases, failing to promote BCR signaling induced by cytoskeleton disruption. CD19 mobility increased even more by treating *Cd81*^−/−^ cells with LatA ([@bib30]). We concluded that CD19 diffusion correlates with CD81 expression and in the absence of CD81, CD19 diffusion is partially controlled by the actin cytoskeleton. We now propose that in the absence of WIP, altered dynamics of the actin cytoskeleton together with a diminished expression of CD81 induce a faster diffusion of CD19. This might cause a dysregulated function of CD19 because both its diffusion and organization might be altered. In line with this suggestion, ligand-independent actin cytoskeleton disruption induced a delayed Ca^2+^ flux and almost absent signaling in B cells lacking WIP.

A growing body of evidence suggests a crucial role for changes in actin dynamics in mediating signal integration from a multitude of surface receptors. On the basis of our findings, we propose that WIP, and possibly other actin regulators, are essential to control correct organization of the actin cytoskeleton and receptor mobility. This might be especially critical in the case of a low amount of signaling (e.g., monovalent antigen) or tonic signaling requiring signal amplification via CD19. Altered receptor dynamics, such as seen in the absence of WIP, might hamper receptor crosstalk and limit CD19 in its function as a general hub for PI3K signaling, thereby influencing critical survival and differentiation signals for mature B cells.

Experimental Procedures {#sec4}
=======================

For an extended description of experimental procedures, see the [Supplemental Information](#app2){ref-type="sec"}.

Mice {#sec4.1}
----

*Wipf1*^*−/−*^ mice ([@bib2]) were a kind gift from Raif Geha (Boston's Children Hospital); Igh-J^tm1Dhu^ mice (BALB/c JHT; [@bib10]) were purchased from Taconic Bioscience; CBy.SJL(B6)-Ptprc^a^/J mice (BALB/c CD45.1) were purchased from The Jackson Laboratory. BALB/c WT and C57BL/6 WT mice, *CD19*^cre+/+^ (referred to as *Cd19*^*−/−*^) ([@bib40]) mice were obtained from the breeding facility at Cancer Research UK (CRUK). Gene targeted mice were bred and maintained at the animal facility of CRUK. Radiation chimeras were generated using standard protocols. Mixed chimeras were generated by injecting a mixture of 80% of Balb/c JHT with 20% WT or *Wipf1*^*−/−*^ BM into Balb/c JHT or Balb/c CD45.1 mice or by injecting a 1:1 mixture of Balb/c CD45.1 WT and CD45.2 *Wipf1*^*−/−*^ into CD45.1 mice. All experiments were approved by the Animal Ethics Committee of Cancer Research UK and the UK Home Office.

Immunization and Infection {#sec4.2}
--------------------------

For infection, mice were injected with a low dose (1 × 10^4^ PFU) of Vaccinia virus WR strain (VV) intra footpad and mice sacrificed 8 days later. Draining popliteal lymph nodes were analyzed by flow cytometry. For immunization, mice were injected i.p. with 50 μg NP33-KLH (Biosearch Technology) in 4 mg Alum (ThermoScientific).

Immunoblotting {#sec4.3}
--------------

Splenic naive B were purified using negative B cell isolation kits yielding enriched populations of about 95%--98% (Miltenyi). Purified splenic B cells were stimulated with 3 μg/mL anti-κ antibody (HB558, ATCC), 200 ng/ml BAFF (Peprotech), 2.5 ng/ml CXCL12, 0.5 μg/mL CXCL13, 0.5 μg/mL CD40L (all R&D systems), 5 μg/mL LPS, or 1 μM Latranculin A (Calbiochem). Lysates were prepared using lysis buffer with 1% NP-40. Immunoblotting was performed using standard procedures. Blot densitometry analysis was performed using the ImageJ software.

Generation of *Wipf1*^*−/−*^ Cell Lines {#sec4.4}
---------------------------------------

WIP was deleted in A20 cells and WEHI-231 cells using CRISPR/Cas9 system ([@bib11; @bib37]). Briefly, custom-designed plasmids expressing the gRNA and Cas9-GFP protein in a single vector (U6gRNA-Cas9-2A-GFP) were bought from Sigma-Aldrich. The following target sites within the coding region of WIP were used: CACTGGCGCCGGCTCCCTTTGG and AGGGAGCCGGCGCCAGTGCTGG. The cell lines were transiently transfected with the desired vector for 12 hr followed by single-cell sorting of GFP-positive cells into a 96-well plate containing complete B cell medium. After 2 weeks, the individual colonies were screened for WIP deletion by immunoblotting.

Single Particle Tracking {#sec4.5}
------------------------

Single particle tracking was performed and analyzed as previously described ([@bib30; @bib47]). Briefly, primary naive B cells were labeled with limiting dilutions of Atto633 or Atto488 conjugated anti-CD19 Fab (1D3), anti-IgD Fab (11-26c), or anti-IgM Fab (Jackson ImmunoResearch) for 10 min on ice and washed with PBS. Cells were then resuspended in imaging buffer and allowed to settle on anti-MHCII-coated coverslips in Focht Chamber System 2 (FCS2) chambers (Bioptechs) at 37°C for 2 min prior to imaging with TIRFM for 15 min. Single particle tracking data was analyzed and confinement size was calculated as described ([@bib30; @bib47]).

Experimental Data and Statistical Analysis {#sec4.6}
------------------------------------------

All statistical comparisons were carried out using the nonparametric two-tailed Student's t test and p values were calculated using PRISM software. Statistically significant differences are indicated on the figures as follows: ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001, ^∗∗∗∗^p \< 0.0001.
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![B Cell-Specific WIP Deficiency Compromises Humoral Immune Responses\
JHT-WT or JHT-*Wipf1*^*−/−*^ mixed BM chimeric mice were infected intra footpad with Vaccinia virus (A) or immunized intra-peritoneally with NP-KLH in alum (B--D).\
(A) Analysis of immune responses in popliteal lymph nodes at day 8 post-infection by flow cytometry. GC cells (B220^+^CD95^+^GL7^+^) or Tfh cells (CD4^+^CD44^+^CD62L^−^PD-1^+^CXCR5^+^) are shown. Quantifications (right column) indicate the percentage of GC B cells or Tfh cells per lymph node analyzed (mean ± SEM).\
(B and C) Analysis of splenic NP-specific GC cells (NP^+^B220^+^CD95^+^GL7^+^) at day 13 post-immunization by flow cytometry. Immunohistochemistry showing IgD^+^ B cell follicles, Bcl-6 expressing GC cells and TCR-β^+^ T cell areas in frozen spleen sections. Graph indicates quantifications of GC cells in spleen sections (mean ± SEM). Scale bar, 150 μm.\
(D) ELISA of NP-specific IgM, IgG, IgG1, and IgG3 antibodies in the sera of immunized chimeras at indicated time points (mean ± SEM).\
Data are representative of two independent experiments (eight mice each).\
See also [Figure S1](#mmc1){ref-type="supplementary-material"}.](gr1){#fig1}

![WIP Deficiency Affects B Cell Homing and Chemotaxis\
(A) Flow cytometric analysis of BM mixture (B220^+^CD45.1^+^ WT and B220^+^CD45.2^+^*Wipf1*^*−/−*^ BM in a mixture of 1:1) before transfer into irradiated recipients.\
(B) Flow cytometric analysis of WT cells (B220^+^CD45.1^+^) and *Wipf1*^*−/−*^ cells (B220^+^CD45.2^+^) in indicated organs of mixed BM chimeras (upper row). Graphs (±SEM) indicate the percentage of B220^+^CD45.1^+^ WT and B220^+^CD45.2^+^*Wipf1*^*−/−*^ cells in respective organs. Data are representative of three independent experiments (n ≥ 4 mice).\
(C) Representative two-photon microscopy images 24 hr after adoptive transfer of labeled WT (cyan) and *Wipf1*^*−/−*^ (red) B cells. Left image is a whole fixed popliteal lymph node (scale bar, 150 μm). B cell follicles are highlighted in gray for illustrative purposes. Middle and right images are examples of the visualization (including representative tracks) of homeostatic movement (scale bars, 30 μm). Smaller images indicate two representative cells, highlighted by arrows at different times. Graphs (±SEM) on the bottom right indicate the quantification of the average speed over the span of the movie and the mean displacement length. Data are representative of three independent experiments.\
(D) Chemotactic response of purified WT and *Wipf1*^*−/−*^ B cells to CXCL12 (left graph) or CXCL13 (right graph) using transwell plates. Graphs (±SEM) show percentages of migrating cells normalized to the starting input number of B cells set to 100%. Data are pooled from four independent experiments.\
(E) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells treated with CXCL12 or CXCL13 and probed with antibodies as indicated.\
(F) Quantifications of intensity of proteins normalized by densitometry to total Erk or tubulin and to the signal in unstimulated WT cells at t = 0. Data are representative of at least three independent experiments.\
See also [Figure S2](#mmc1){ref-type="supplementary-material"}and [Movie S1](#mmc2){ref-type="supplementary-material"}.](gr2){#fig2}

![WIP Is Required for Efficient BCR-Induced Activation of the PI3K Pathway\
(A) TIRF microscopy of WEHI-231 B cells expressing GFP-WIP imaged after spreading over a planar lipid bilayer labeled with anti-κ-chain antibody linked to Alexa Fluor 633 (left) and quantification of fluorescent intensities along the white diagonal line (right, colors match labels above images). Scale bar, 3 μm.\
(B) Flow cytometric analysis of WIP phosphorylation after anti-κ-chain stimulation of WT B cells. Grey shaded histogram represents the unstimulated WT control. Graph shows the mean fluorescent intensity (MFI) normalized to the MFI of *Wipf1*^*−/−*^ cells at indicated time points.\
(C) Phalloidin staining indicating intracellular amount of F-actin in fixed WT or *Wipf1*^*−/−*^ B cells settled on coverslips coated with anti-κ-chain antibody for 10 min. Scale bar, 3 μm. Quantification (right graph) shows F-actin foci per cell (mean ± SEM). Data are representative of three independent experiments.\
(D and E) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells stimulated with anti-κ-chain antibody and probed with antibodies as indicated. Quantifications of intensity of proteins normalized by densitometry to total Erk or tubulin and to the signal in unstimulated WT cells at t = 0. Data are representative of at least three independent experiments.\
(F) Graph show mean (±SEM) percentage of live WT or *Wipf1*^*−/−*^ B cells cultured in medium or in the presence of BAFF at different time points, normalized to the starting input number of live B cells set to 100%. Results pooled from three independent experiments with one mouse each.\
(G) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells stimulated with BAFF, probed with antibodies against p-Akt and Erk. Quantifications of intensity of proteins normalized by densitometry to total Erk and to the signal in unstimulated WT cells at t = 0.\
(D and G) Experiments were performed simultaneously with experiments in [Figure 5](#fig5){ref-type="fig"}A and therefore results can be directly compared. The loading control measurements (Erk for anti-κ-chain and BAFF stimulation) were part of both experiments.\
See also [Figure S3](#mmc1){ref-type="supplementary-material"}and [Movie S2](#mmc3){ref-type="supplementary-material"}.](gr3){#fig3}

![WIP Regulates PI3K Signaling and Mediates Class-Switching and Plasma Cell Formation In Vitro\
(A and B) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells stimulated with CD40L (A) or LPS (B), probed with antibodies as indicated. Quantifications of intensity of proteins normalized by densitometry to Erk or tubulin, and to the signal in unstimulated WT cells at t = 0. This experiment and experiment in [Figure S4](#mmc1){ref-type="supplementary-material"}D were performed simultaneously. The loading control measurements were part of both experiments.\
(C and D) CTV labeled splenic WT and *Wipf1*^*−/−*^ B cells were stimulated for 4 days with CD40L (C) or LPS (D) and IL-4 and IL-5. Flow cytometry measurements of proliferation (CTV dilution, upper row), class-switch recombination (IgG1^+^ cells, middle row) and plasma cell differentiation (CD138^hi^ cells, lower row). Graphs on the right of (C) and (D) indicate the percentages of class-switched and PCs normalized to total live cells. Data are pooled from at least three experiments (mean ± SEM).\
See also [Figure S4](#mmc1){ref-type="supplementary-material"}.](gr4){#fig4}

![WIP Regulates PI3K Activation via Phosphorylation of CD19\
(A) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells stimulated with (from top to bottom) anti-κ-chain antibody, BAFF, CC40L, LPS, CXCL12, or CXCL13 and probed with antibodies as indicated. Experiments were performed simultaneously with experiments in [Figure 3](#fig3){ref-type="fig"} (anti-κ-chain and BAFF), [Figure 4](#fig4){ref-type="fig"} (LPS) and [Figure S2](#mmc1){ref-type="supplementary-material"}D (CXCL12 and CXCL13). Single loading control measurements are shown in figures.\
(B) Quantifications of intensity of proteins stimulated as in (A) normalized by densitometry to Erk or tubulin and to the signal in unstimulated WT cells at t = 0.\
(C--F) CTV labeled splenic WT and *Cd19*^*−/−*^ B cells were stimulated for 4 days with CD40L and IL-4 and IL-5. Flow cytometry measurements of (C) proliferation (CTV dilution), (D) class-switch recombination (IgG1^+^ cells, upper row) and plasma cell differentiation (CD138^hi^ cells, lower row). Graphs on the right of (D) indicate the percentages of class-switched and PCs normalized to total live cells. Data are pooled from at least three experiments (mean ± SEM).\
(E and F) Immunoblot of splenic WT or *Cd19*^*−/−*^ B cells stimulated with CD40L and probed with antibodies as indicated. Quantifications of intensity of proteins normalized by densitometry to actin and to the signal in unstimulated WT cells at t = 0.\
(G) Chemotactic response of purified WT and *Cd19*^*−/−*^ B cells to CXCL13 using transwell plates. Graphs (±SEM) show percentages of migrating cells normalized to the starting input number of B cells set to 100%. Data are pooled from three independent experiments.\
(H) Immunoblot of splenic WT or *Cd19*^*−/−*^ B cells stimulated with CXCL13 and probed with antibodies as indicated. Quantifications of intensity of proteins normalized by densitometry to Erk and to the signal in unstimulated WT cells at t = 0.\
See also [Figure S5](#mmc1){ref-type="supplementary-material"}.](gr5){#fig5}

![WIP Regulates BCR and CD19 Diffusion on the B Cell Surface\
(A) Flow cytometric analysis of CD19 and CD81 on the surface of WT (blue line) or *Wipf1*^*−/−*^ (red line) B cells. Grey shaded histogram indicates the isotype control. Graph (mean ± SEM) on the right shows the MFI of CD81 expression on splenic B cells of 4 WT and 4 *Wipf1*^−/−^ mice.\
(B) Single-particle tracking (SPT) of CD19 on WT or *Wipf1*^*−/−*^ B cells settled on nonstimulatory coverslips. Shown is the diffusion coefficient (D) in μm^2^/s. The median of 300 representative cells is given as value and indicated by black bars. 1,000--2,000 tracks were analyzed with a minimum of 20 cells from 3 experiments.\
(C) Trajectories of CD19 in WT (left) and *Wipf1*^*−/−*^ cells (right) showing diffusion of single particles over 10 s and magnified regions from white rectangles. Scale bar, 2 μm.\
(D) Analysis of the CD19 diffusion coefficient plotted in a logarithmic histogram and fitted to two distinct populations exhibiting slower (light gray) and faster (dark gray) diffusion on WT (left graph), *Wipf1*^*−/−*^ (middle graph) and a comparison of the CD19 diffusion on WT and *Wipf1*^*−/−*^ B cells (right graph).\
(E) Flow cytometric analysis of F-actin by intracellular phalloidin staining of resting WT (blue line) or *Wipf1*^*−/−*^ (red line) B cells.\
(F) SPT of IgM and IgD on WT or *Wipf1*^*−/−*^ B cells settled on nonstimulatory coverslips. Shown is the diffusion coefficient (D) in μm^2^/s. 1,000--2,000 tracks were analyzed with a minimum of 20 cells from 2 experiments. The median of 300 representative cells is given as value and indicated by black bars.\
(G) Ratiometric intracellular Ca^2+^ flux of WT and *Wipf1*^*−/−*^ B cells, stimulated with Latranculin A and analyzed by flow cytometry. Results are presented as fluorescent emission at 450 nm relative to that at 530 nm. Data are representative of three independent experiments.\
(H) Immunoblot of splenic WT or *Wipf1*^*−/−*^ B cells stimulated with Latrunculin A and probed with antibodies as indicated. Quantifications of intensity of proteins normalized by densitometry to Erk or tubulin and to the signal in unstimulated WT cells at t = 0.\
See also [Figure S6](#mmc1){ref-type="supplementary-material"} and [Movie S3](#mmc4){ref-type="supplementary-material"}.](gr6){#fig6}
